Nuvalent, Inc. (NUVL)
102.08
-0.91
(-0.88%)
USD |
NASDAQ |
Feb 10, 16:00
102.10
+0.02
(+0.02%)
Pre-Market: 20:00
Nuvalent Total Liabilities (Quarterly) : 134.51M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | -- |
| Vanda Pharmaceuticals, Inc. | 135.14M |
| ACADIA Pharmaceuticals, Inc. | 413.50M |
| Alnylam Pharmaceuticals, Inc. | 4.618B |
| Savara, Inc. | 46.54M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 979.91M |
| Shareholders Equity (Quarterly) | 845.40M |
| Current Ratio | 10.73 |